Differences

This shows you the differences between two versions of the page.

--- home:symptoms:gastrointestinal [12.21.2018] – [Introduction] sallieq
+++ home:symptoms:gastrointestinal [03.13.2019] – [Bleeding from bowel] sallieq
@@ Line 17: / Line 17: @@
   * **[[home:symptoms:gastrointestinal:constipation|Constipation]]** – A condition of the digestive system in which a person experiences hard feces that are difficult to expel. In certain cases, constipation may be caused by medications, such as opioids, or food intake.
   * **[[home:symptoms:gastrointestinal:diarrhea|Diarrhea]]** – The excessive and frequent evacuation of watery feces and is commonly reported in those patients with [[home:diseases:ibd|Crohn's disease]], [[home:diseases:ibd|inflammatory bowel disorder]], and other disease caused by infections of the gastrointestinal tract.
-  * liver and gall bladder
   * rectal
     * [[home:diseases:ibd|inflammatory bowel disease]]
@@ Line 56: / Line 56: @@
 ==== Bleeding from bowel ====
-Small streaks of bright red blood are less likely to be cause for concern, but darker blood in a bowel movement will require investigation: when your doctor needs you to have a [[https://medical-dictionary.thefreedictionary.com/Colonoscopy|colonoscopy]], this will take considerable time and require preparation.
+Small drops of bright red blood are less likely to be cause for concern, but darker blood in a bowel movement will definitely require investigation: when your doctor needs you to have a [[https://medical-dictionary.thefreedictionary.com/Colonoscopy|colonoscopy]], this will take considerable time and require preparation.
 {{tag>gastrointestinal symptoms }}
+==== Further researxh ====
+Findings suggest that neither olmesartan nor other ARBs were associated with diarrhea among patients undergoing endoscopy. The spruelike enteropathy recently associated with olmesartan is likely a rare adverse effect and milder presentations are unlikely.  (({{pubmed>long:25023670}}))
+In a methotrexate-induced model of intestinal mucositis, olmesartan reduced inflammation and induced enteropathy characterized by severe diarrhea, weight loss, and reduced sucrose activity.   (({{pubmed>long:25947920}}))

home/symptoms/gastrointestinal.txt · Last modified: 09.14.2022 by 127.0.0.1